Overview

Autonomic Blockade and Endogenous Glucose Production

Status:
Withdrawn
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The investigators will test the null hypothesis that there will be no changes in the insulin-mediated suppression of endogenous glucose production (EGP) in response to autonomic blockade. To test this hypothesis, the investigators propose to determine the role of the autonomic nervous system in hepatic insulin resistance.
Phase:
Phase 1
Details
Lead Sponsor:
Vanderbilt University Medical Center
Treatments:
Insulin
Trimethaphan
Trimethaphan camsylate